MediCane Health is an international pharmaceutical company engaged in the research, development, production, and marketing of cannabis-based medications. With operational subsidiaries in Israel, Portugal, and a commercial hub in Germany, the company focuses on European countries that promote legislation for medical cannabis.
MediCane aims to advance medical research and development in different therapeutic areas, exploring the connection between the use of cannabis plant components and improving the health of patients with various medical conditions. MediCane wishes to contribute to the symptom relief of people whose needs cannot be met through traditional drug treatments.
MediCane develops products in two parallel regulatory pathways: the medical cannabis route, using whole plant extractions, and the pharmaceutical route, using isolated ingredients. MediCane controls the seed-to-customer value chain to ensure delivery of its highest quality pharmaceutical-grade products to patients in need.
MediCane conducts various clinical trials in collaboration with scientists and physicians in different fields, with the support of academic research institutions and hospitals in Israel, UK, Portugal, Spain, and more.